论文信息 - LBA37 A randomized, multicentric phase II study of preoperative nivolumab plus relatlimab or nivolumab in patients with resectable non-small cell lung cancer (NEOpredict-Lung) - 字舞流文

LBA37 A randomized, multicentric phase II study of preoperative nivolumab plus relatlimab or nivolumab in patients with resectable non-small cell lung cancer (NEOpredict-Lung)

K. Darwiche | P. Baas | M. Wiesweg | H. Hautzel | B. Hegedűs | C. Aigner | A. Schramm | H. Schildhaus | T. Ploenes | M. Vanbockrijck | M. Schuler | B. Maes | K. Cuppens | D. Theegarten | B. Du Pont | K. Hartemink